ArticleFrontiers in immunology2023

Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients.

Ruixuan Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.